Hao Q. Wei

Chengdu, 611137, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Targeting Glycolytic Plasticity to Overcome Therapy Resistance in Cancer Stem Cells: Mechanisms and Clinical Perspectives.

Targeting Glycolytic Plasticity to Overcome Therapy Resistance in Cancer Stem Cells: Mechanisms and Clinical Perspectives.

Journal: Cells

Published: May 13, 2026

Safety and efficacy of the MNK/VEGFR inhibitor JDB153 combined with the anti-PD-1 antibody serplulimab in patients with advanced pancreatic cancer refractory to standard treatment: a single-arm, phase Ib/II study protocol.

Safety and efficacy of the MNK/VEGFR inhibitor JDB153 combined with the anti-PD-1 antibody serplulimab in patients with advanced pancreatic cancer refractory to standard treatment: a single-arm, phase Ib/II study protocol.

Journal: Frontiers in pharmacology

Published: February 06, 2026

The role of systemic immune-inflammation Index in predicting the diagnosis of severe pneumonia in children.

The role of systemic immune-inflammation Index in predicting the diagnosis of severe pneumonia in children.

Journal: Frontiers in pediatrics

Published: January 12, 2026

Clinical Efficacy of Early and Late Vedolizumab or Infliximab Interventions in Moderate Ulcerative Colitis: A Multicenter, Retrospective Cohort Study.

Clinical Efficacy of Early and Late Vedolizumab or Infliximab Interventions in Moderate Ulcerative Colitis: A Multicenter, Retrospective Cohort Study.

Journal: Gastroenterology research

Published: September 29, 2025

Targeting NKG2D/NKG2DL axis in cancer immunotherapy: mechanisms and therapeutic applications.

Targeting NKG2D/NKG2DL axis in cancer immunotherapy: mechanisms and therapeutic applications.

Journal: Journal of translational medicine

Published: September 17, 2025

Lycium barbarum-probiotic synergy alleviates chemotherapy-induced cancer-related fatigue via gut microbiota-metabolic axis regulation in mice.

Lycium barbarum-probiotic synergy alleviates chemotherapy-induced cancer-related fatigue via gut microbiota-metabolic axis regulation in mice.

Journal: Frontiers in nutrition

Published: April 16, 2025

Effects of Gamma-Ray Irradiation of Bacteria Colonies in Animal Feeds and on Growth and Gut Health of Weaning Piglets.

Effects of Gamma-Ray Irradiation of Bacteria Colonies in Animal Feeds and on Growth and Gut Health of Weaning Piglets.

Journal: Animals : an open access journal from MDPI

Published: September 30, 2023

Oral compound probiotic supplements can improve the quality of life for patients with lung cancer during chemotherapy: A randomized placebo-controlled study.

Oral compound probiotic supplements can improve the quality of life for patients with lung cancer during chemotherapy: A randomized placebo-controlled study.

Journal: Thoracic cancer

Published: September 27, 2023

Prolyl hydroxylase 2 inhibits glycolytic activity in colorectal cancer via the NF‑κB signaling pathway.

Prolyl hydroxylase 2 inhibits glycolytic activity in colorectal cancer via the NF‑κB signaling pathway.

Journal: International journal of oncology

Published: September 17, 2023

Bone health in inflammatory bowel disease.

Bone health in inflammatory bowel disease.

Journal: Expert review of gastroenterology & hepatology

Published: August 17, 2023

Correction: Li et al. Fringe Projection Profilometry Based on Saturated Fringe Restoration in High Dynamic Range Scenes. Sensors 2023, 23, 3133.

Correction: Li et al. Fringe Projection Profilometry Based on Saturated Fringe Restoration in High Dynamic Range Scenes. Sensors 2023, 23, 3133.

Journal: Sensors (Basel, Switzerland)

Published: June 01, 2023

Huo Xiang Zheng Qi Oral Liquid Combined with 5-HT3 Receptor Antagonists and Dexamethasone Can Prevent Chemotherapy-Induced Nausea and Vomiting for Patients Receiving Multiday Cisplatin-Based Regimen: A Multicenter Trial.

Huo Xiang Zheng Qi Oral Liquid Combined with 5-HT3 Receptor Antagonists and Dexamethasone Can Prevent Chemotherapy-Induced Nausea and Vomiting for Patients Receiving Multiday Cisplatin-Based Regimen: A Multicenter Trial.

Journal: Journal of integrative and complementary medicine

Published: March 31, 2023

Showing 1-12 of 23

Last Updated: 09/26/2026